|
Symbol
|
WEVLTQ | XRMLTQ | OCGRCH | OOJRCH | AAXSTQ | SKS5LK | ABSFTQ | POMRCH | POLRCH | PRXRCH | ACDQTQ | PWCRCH | Z0AZ2Z | Z0AZ1Z | Z0AZ0Z | Z0AZ3Z | RMAASV | ADOZTQ | ADRATQ | ADSWTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Autocallable Reverse Convertible | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | ZKB Reverse Convertible on worst of Last Look | Multi Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Mitsubishi UFJ Financial Group Inc. / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Barry Callebaut AG / Nestlé S.A. / Roche PS / Swiss RE AG / UBS Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Kühne & Nagel Intl. AG / Swatch Group I / UBS Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Swiss Re / UBS / Zurich | ABB / Kühne & Nagel Intl. AG / Logitech International SA / UBS Group AG | Companie Financière Richemont SA / Logitech International SA / UBS Group AG | Adecco Group AG / Logitech International SA / Stadler Rail AG / Straumann Hldg. AG / UBS Group AG | Kühne & Nagel Intl. AG / Logitech International SA / Lonza Group N / Swiss RE AG / UBS Group AG | Deutsche Bank AG / Julius Baer Group / UBS Group AG | Deutsche Bank AG / Julius Baer Group / UBS Group AG | Deutsche Bank AG / Julius Baer Group / UBS Group AG | Deutsche Bank AG / Julius Baer Group / UBS Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swissquote Group Hldg. S.A. / UBS Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Partners Group Hldg. AG / UBS Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
31.03.2028 | 06.07.2026 | 26.04.2027 | 15.07.2026 | 13.09.2027 | 14.10.2026 | 20.12.2027 | 31.07.2026 | 03.02.2027 | 24.02.2027 | 21.03.2030 | 27.06.2029 | 09.04.2027 | 09.04.2027 | 09.04.2027 | 09.04.2027 | 26.04.2027 | 24.07.2026 | 04.08.2028 | 11.08.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
71,27 | 1 034,00 | 58,5776 | 997,10 | 43,77 | 168,45 | 37,59 | 103,5375 | 53,638 | 61,334 | 18,434 | 89,05 | 39,0998 | 39,0998 | 39,1336 | 39,1269 | 793,50 | 843,00 | 35,72 | 555,00 |
| rendement max. p.a. | 4,24% | - | 3,66% | - | 2,45% | 6,68% | 2,28% | - | 6,35% | 9,51% | 13,59% | 6,93% | 6,39% | 4,75% | 2,70% | 6,28% | 25,32% | 407,46% | 3,24% | 8,52% |
| Demande | 100,34 | - | 100,19 | 100,78 | 101,19 | - | 101,15 | 100,71 | 99,26 | 97,14 | 77,32 | 93,11 | - | - | - | - | 88,30 | 80,18 | 99,46 | 90,74 |
| Offre | 101,15 | - | 100,99 | - | 102,00 | - | 101,96 | - | 100,06 | 97,94 | 78,10 | 93,91 | - | - | - | - | 89,30 | 80,98 | 100,26 | 91,54 |